Cronos Group Inc Stock

$1.90

0.52% yesterday

Nasdaq, Jun 27, 10:05 pm CET

ISIN

CA22717L1013

Symbol

CRON

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Cronos Group Inc Stock price

$1.90

-4.20 68.85% 5Y

Nasdaq, Closing price Fri, Jun 27 2025

-0.01 0.52%

ISIN

CA22717L1013

Symbol

CRON

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Key metrics

Basic

Market capitalization

$733.7m

Enterprise Value

$-104.2m

Net debt

$-837.8m

Cash

$837.8m

Shares outstanding

385.4m

Valuation (TTM | estimate)

P/E

15.83 | negative

P/S

5.89 | 4.97

EV/Sales

negative | negative

EV/FCF

13.76

P/B

0.69

Financial Health

Equity Ratio

91.23%

Return on Equity

3.86%

ROCE

-4.39%

ROIC

-17.19%

Debt/Equity

0.00

Financials (TTM | estimate)

Revenue

$124.6m | $147.6m

EBITDA

$-46.1m | $-1.4m

EBIT

$-49.2m

Net Income

$49.4m | $-17.0m

Free Cash Flow

$-7.6m

Growth (TTM | estimate)

Revenue

33.92% | 25.48%

EBITDA

32.59% | 97.55%

EBIT

32.67%

Net Income

186.68% | -141.46%

Free Cash Flow

-627.88%

Margin (TTM | estimate)

Gross

27.65%

EBITDA

-37.00% | -0.93%

EBIT

-39.47%

Net

39.68% | -11.54%

Free Cash Flow

-6.07%

EPS

$0.12

FCF per Share

$-0.02

Short interest

1.44%

Employees

459.00

Rev per Employee

$260.00k

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Get Started for Free Today

Cronos Group Inc Stock Analysis

Unlock Scores for Free

??

10 Analysts have issued a Cronos Group Inc forecast:

7x Buy

70%

2x Hold

20%

More details on Analyst Estimates Including Price Targets

10 Analysts have issued a Cronos Group Inc forecast:

Buy

70%

Hold

20%

Sell

10%

Analyst Estimates with Stock Price Targets

Financial data from Cronos Group Inc

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	125 125	34% 34% 100%
- Direct Costs	90 90	13% 13% 72%
Gross Profit	34 34	156% 156% 28%
- Selling and Administrative Expenses	77 77	1% 1% 61%
- Research and Development Expense	4.03 4.03	16% 16% 3%
EBITDA	-46 -46	33% 33% -37%
- Depreciation and Amortization	3.07 3.07	34% 34% 2%
EBIT (Operating Income) EBIT	-49 -49	33% 33% -39%
Net Profit	49 49	187% 187% 40%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Cronos Group Inc Stock News

Neutral

GlobeNewsWire

●

5 days ago

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders

TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company o...

Neutral

MarijuanaStocks

●

8 days ago

3 Cannabis Stocks For Investors To Secure For Future Gains

The current state of the cannabis sector has people feeling a type of way. To be more descriptive, those who are invested in marijuana stocks are feeling the backlash of the market. For some time, there has been a sharp decline in the overall trading for most top marijuana stocks. Now, you would think that with the sector down and showing no true signs of recovery, all is lost. That is not the ...

Positive

MarijuanaStocks

●

17 days ago

3 Marijuana Stocks For Longterm Investors

The volatile downtrend for marijuana stocks has been both bitter and sweet. On the one hand, you have the sector trading at all-time lows. The upside to this is being able to pick up shares at a cheap price. But the sector is not as active as it once was and outside of politics, it's been challenging to find a catalyst for the sector to bounce. Nonetheless, the sweeter part is knowing that the ...

More Cronos Group Inc News

Company Profile

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Head office	Canada
CEO	Michael Gorenstein
Employees	459
Founded	2012
Website	thecronosgroup.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now